Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Vaiheen 3B/4 satunnaistettu turvallisuuspäätetapahtumatutkimus, jossa verrataan kahta tofasitinibiannosta tuumorinekroositekijän (TNF) estäjään nivelreumaa sairastavilla tutkittavilla.
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 4
Medicine: XELJANZ®(TOFACITINIB)
Language: Finnish
ViewDownloadPrint
A Long-Term Study to Assess the Safety of Tofacitinib in Participants With Juvenile Idiopathic Arthritis (JIA)
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 2/3
Medicine: XELJANZ®(TOFACITINIB)
Language: English
ViewDownloadPrint
A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
Category & Conditions: Cancer
Study Phase : 3
Medicine: ZIRABEV INJECTION(BEVACIZUMAB-BVZR)
Language: English
ViewDownloadPrint
Study Comparing Single Doses of Abrocitinib Tablets and Abrocitinib Liquid Medicine Taken Alone and After Famotidine Antacids
Category & Conditions: Skin Diseases and Conditions
Study Phase : 1
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint
Study Investigating Blood Levels of Caffeine, Efavirenz, and Omeprazole When Taken Before and After Abrocitinib in Healthy Participants
Category & Conditions: Skin Diseases and Conditions
Study Phase : 1
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint
Study of Inflammation in the Skin of Participants with Atopic Dermatitis Treated with Abrocitinib
Category & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint
Study to Measure the Efficacy and Safety of Abrocitinib (PF-04965842) in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis (JADE Mono-1)
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint
Study to Measure the Efficacy and Safety of Abrocitinib (PF-04965842) in Subjects Aged 12 Years And Older, With Moderate to Severe Atopic Dermatitis
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint
Study to Measure the Efficacy and Safety of Abrocitnib Versus Placebo and Dupilumab to Treat Moderate to Severe Atopic Dermatitis in Adults Receiving Background Topical Therapy
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis (JADE TEEN)
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
Language: English
ViewDownloadPrint